Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Evogene Ltd. (EVGN) had Free Cash Flow per Share of $-0.30 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.33M |
|
$-5.87M |
|
$0.13M |
|
$0.20M |
|
$3.48M |
|
$-3.15M |
|
$-2.76M |
|
$-5.91M |
|
$-5.91M |
|
$-5.90M |
|
$-5.91M |
|
$-5.90M |
|
$-5.90M |
|
$-3.15M |
|
$-1.23M |
|
9.74M |
|
9.74M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$14.96M |
|
$0.74M |
|
$2.98M |
|
$17.95M |
|
$5.36M |
|
-- |
|
$4.59M |
|
$9.96M |
|
$7.99M |
|
$7.99M |
|
$7.99M |
|
10.41M |
|
| Cash Flow Statement Financials | |
$-2.95M |
|
$-4.49M |
|
$2.99M |
|
$12.96M |
|
$8.51M |
|
$-4.45M |
|
$-0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
61.08% |
|
-943.11% |
|
-943.11% |
|
-- |
|
-1768.26% |
|
-1757.48% |
|
$-2.93M |
|
-- |
|
-- |
|
-- |
|
0.02 |
|
0.74 |
|
0.20 |
|
458.62 |
|
-73.97% |
|
-73.97% |
|
-32.93% |
|
-73.97% |
|
$0.77 |
|
|
Free Cash Flow per Share |
$-0.30 |
$-0.30 |
|